RADIATION-INDUCED XEROSTOMIA
Clinical trials for RADIATION-INDUCED XEROSTOMIA explained in plain language.
Never miss a new study
Get alerted when new RADIATION-INDUCED XEROSTOMIA trials appear
Sign up with your email to follow new studies for RADIATION-INDUCED XEROSTOMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gene therapy aims to restore saliva in cancer survivors
Disease control OngoingThis study tests a gene therapy designed to help people with dry mouth after radiation for head and neck cancer. The treatment delivers a gene into one saliva gland to help it produce more saliva. The trial includes 17 adults and focuses on safety, with follow-up over three years…
Matched conditions: RADIATION-INDUCED XEROSTOMIA
Phase: PHASE1 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a single gene therapy dose restore saliva flow years after radiation?
Symptom relief OngoingThis study follows people who received an experimental gene therapy, AAV2hAQP1, for chronic dry mouth caused by past radiation treatment for cancer. Researchers are checking whether the therapy remains safe and whether any improvement in saliva production lasts over time. The goa…
Matched conditions: RADIATION-INDUCED XEROSTOMIA
Sponsor: MeiraGTx, LLC • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC